BPG is committed to discovery and dissemination of knowledge
Featured Articles
10/14/2020 1:56:06 PM | Browse: 669 | Download: 2051
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 55301
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report
Manuscript Source Unsolicited Manuscript
All Author List Shu-Guang Zhu, Hai-Bo Li, Ze-Nan Yuan, Wei Liu, Qing Yang, Ying Cheng, Wen-Jing Wang, Guo-Ying Wang and Hua Li
Funding Agency and Grant Number
Funding Agency Grant Number
National 13th Five-Year Science and Technology Plan Major Projects of China 2017ZX10203205-006-001
Sci-tech Research Development Program of Guangzhou City 201607010024
Science and Technology Planning Project of Guangdong Province 2017B020209004
Corresponding Author Guo-Ying Wang, MD, PhD, Doctor, Doctor, Surgeon, Department of Hepatic Surgery and Liver Transplantation, The Third Affiliated Hospital of Sun Yat-Sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou 510000, Guangdong Province, China. wanggy3@126.com
Key Words Sarcomatoid hepatocellular carcinoma; Hepatocellular carcinoma; Programmed death-ligand 1; Immunotherapy; Nivolumab; Case report
Core Tip Here, we report a rare case of advanced sarcomatoid hepatocellular carcinoma (SHC), which was successfully treated with the anti-programmed cell death 1 antibody. To the best of our knowledge, this is the first case report on the successful treatment of advanced SHC using immunotherapy.
Publish Date 2020-10-14 13:53
Citation Zhu SG, Li HB, Yuan ZN, Liu W, Yang Q, Cheng Y, Wang WJ, Wang GY, Li H. Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report. World J Gastrointest Oncol 2020; 12(10): 1209-1215
URL https://www.wjgnet.com/1948-5204/full/v12/i10/1209.htm
DOI https://dx.doi.org/10.4251/wjgo.v12.i10.1209
Full Article (PDF) WJGO-12-1209.pdf
Full Article (Word) WJGO-12-1209.docx